Pulmonary Hypertension in Infants, Children, and Young Adults
- 1 May 2017
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 69 (20), 2551-2569
- https://doi.org/10.1016/j.jacc.2017.03.575
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Macitentan and Morbidity and Mortality in Pulmonary Arterial HypertensionThe New England Journal of Medicine, 2013
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial HypertensionCirculation, 2012
- Add-On Therapy with Subcutaneous Treprostinil for Refractory Pediatric Pulmonary HypertensionThe Journal of Pediatrics, 2011
- A Consensus Approach to the Classification of Pediatric Pulmonary Hypertensive Vascular Disease: Report from the PVRI Pediatric Taskforce, Panama 2011Pulmonary Circulation, 2011
- Impact of Oral Sildenafil on Exercise Performance in Children and Young Adults After the Fontan OperationCirculation, 2011
- Long-Term Outcomes in Children With Pulmonary Arterial Hypertension Treated With Bosentan in Real-World Clinical SettingsThe American Journal of Cardiology, 2010
- Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in FranceArchives of Cardiovascular Diseases, 2010
- Short- and Long-Term Effects of Inhaled Iloprost Therapy in Children With Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2008
- Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart diseaseHeart, 2007
- Effects of Long-Term Bosentan in Children With Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2005